- Early nuclear alterations and immunohistochemical expression of Ki-67…
Number of the records: 1  

Early nuclear alterations and immunohistochemical expression of Ki-67, Erb-B2, vascular endothelial growth factor (VEGF), transforming growth factor (TGF-BETA 1) and integrine-linked kinase (ILK) two days after tamoxifen in breast carcinoma

  1. TitleEarly nuclear alterations and immunohistochemical expression of Ki-67, Erb-B2, vascular endothelial growth factor (VEGF), transforming growth factor (TGF-BETA 1) and integrine-linked kinase (ILK) two days after tamoxifen in breast carcinoma / A.M.L. Morena ... [et al.]
    Another responsib. Morena, A. M. L. (Author)
    Oshima, C.T.F. (Author)
    Gebrim, L.H. (Author)
    Egami, M.I. (Author)
    Silva, M.R.R. (Author)
    Segreto, R.A. (Author)
    Giannotti Filho, O. (Author)
    Teixeira, V.P.C. (Author)
    Segreto, H.R.C. (Author)
    Translated titleVčasné poškodenie jadra a imunohistochemická expresia Ki-67, Erb-B2, vaskulárneho endoteliálneho rastového faktora (VEGF), transformujúceho rastového faktora (TGF-BETA-1) a integrín-závislej kinázy (ILK) dva dni po podaní tamoxifénu u karcinómu prsnej žľazy
    Phys.des.Obr.
    NoteRes. angl.. Bibliogr. odkazy
    In Neoplasma. -- ISSN 0028-2685. -- Vol. 51, no. 6 (2004), p. 481-486
    Call numberC 720
    MeSH Subject nádory prsníka - diagnostika
    jadro bunkové - genetika
    antigén Ki-67 - účinky nežiaduce
    gény erbB-2 - genetika - imunológia
    faktory rastové endotelové cievne
    faktory rastové transformujúce
    tamoxifén - analógy a deriváty - farmakokinetika
    systematics616.18.19-006.6-085
    LanguageEnglish
    CountrySlovakia
    DatabaseARTICLES
    article

    article

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.